51 – 60 of 335
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis : Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network
- Contribution to journal › Article
-
Mark
Immune tolerance induction : What have we learned over time?
- Contribution to journal › Scientific review
-
Mark
Evaluation of prophylactic therapy in haemophilia with global coagulation tests
- Contribution to journal › Letter
-
Mark
Fifth Åland Island conference on von Willebrand disease
- Contribution to journal › Article
-
Mark
Defining extended half-life rFVIII-A critical review of the evidence
- Contribution to journal › Article
-
Mark
Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII
- Contribution to journal › Article
-
Mark
The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
- Contribution to journal › Article
- 2017
-
Mark
Thrombin generation assays (TGAs)
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy : The Malmö experience
- Contribution to journal › Article
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
- Contribution to journal › Debate/Note/Editorial
